Magnesium
Magnesium evidence quality varies sharply by use case and by form. For blood pressure reduction, multiple meta-analyses of RCTs (including a 2025 meta-analysis of 38 RCTs, PMID 41000008) confirm a modest, statistically significant reduction in systolic and diastolic BP; the effect is clinically meaningful mainly in hypertensive or hypomagnesemic populations and does not consistently reach significance in normotensive individuals (Grade B). For sleep, small RCTs show statistically significant but modest effects on insomnia severity; a 2021 systematic review (PMID 33865376) rates the overall evidence quality as low-to-very-low, and two more recent trials on magnesium L-threonate (PMID 39252819) and bisglycinate (PMID 40918053) show small effect sizes; benefits are plausible but should not be overstated (Grade C). For constipation, magnesium oxide and citrate at pharmacological doses are well-established osmotic laxatives, confirmed in a 2019 RCT (PMID 31587548); this is the highest-evidence use but is form-specific and dose-dependent (Grade A). For migraine prevention, a 2024 meta-analysis (PMID 39404918) supports oral magnesium as a meaningful preventive option with reduced attack frequency, severity, and monthly migraine days (Grade B). Form matters enormously across all uses: oxide is cheap and labels high elemental magnesium but is poorly absorbed (roughly 4% bioavailability) and drives GI side effects. Glycinate, bisglycinate, malate, and citrate are substantially better absorbed. ConsumerLab 2024 testing found products that label themselves as glycinate but appear to contain oxide, which is the core transparency problem this vertical addresses.
Supplemental magnesium above 350 mg/day of elemental magnesium (the NIH Tolerable Upper Intake Level for adults) commonly causes osmotic diarrhea, loose stools, nausea, and abdominal cramping, particularly in poorly absorbed forms such as oxide and citrate. At moderate doses of well-absorbed forms (glycinate, bisglycinate, malate), GI side effects are substantially reduced. In individuals with chronic kidney disease (CKD) or significantly impaired renal function (creatinine clearance below 20-30 mL/min), the kidneys cannot adequately clear magnesium, and supplementation can cause hypermagnesemia leading to cardiac arrhythmia, neuromuscular blockade, and respiratory depression; persons with CKD should not use magnesium supplements without physician supervision. Magnesium can reduce absorption of certain antibiotics (tetracyclines, fluoroquinolones) and bisphosphonates; separate dosing by 2 or more hours. Not a treatment for any disease.
Full safety details belowEvidence by use
Each use graded independently. A strong grade for one use does not carry over to others.
Moderate evidence; some gaps remain.
Emerging and mixed. Not settled.
Strong, consistent human trials.
Moderate evidence; some gaps remain.
Supplemental magnesium above 350 mg/day of elemental magnesium (the NIH Tolerable Upper Intake Level for adults) commonly causes osmotic diarrhea, loose stools, nausea, and abdominal cramping, particularly in poorly absorbed forms such as oxide and citrate. At moderate doses of well-absorbed forms (glycinate, bisglycinate, malate), GI side effects are substantially reduced. In individuals with chronic kidney disease (CKD) or significantly impaired renal function (creatinine clearance below 20-30 mL/min), the kidneys cannot adequately clear magnesium, and supplementation can cause hypermagnesemia leading to cardiac arrhythmia, neuromuscular blockade, and respiratory depression; persons with CKD should not use magnesium supplements without physician supervision. Magnesium can reduce absorption of certain antibiotics (tetracyclines, fluoroquinolones) and bisphosphonates; separate dosing by 2 or more hours. Not a treatment for any disease.
Who takes it and why
Each expert's dose and stated reason, linked to their own words. Attribution only; no endorsement implied.
Photo: Jamesbrianbounds, CC BY-SA 4.0, via Wikimedia Commons ↗Magnesium threonate engages the GABA pathway to help the forebrain transition into sleep, increasing sleep depth and reducing sleep-onset latency. Threonate is noted for potential blood-brain-barrier penetrance relevant to both sleep and cognitive applications. Approximately 5% of people experience stomach agitation from magnesium; in those cases it should not be taken.
www.hubermanlab.com ↗Attribution only; no endorsement implied.
Photo: Jop van Velthuis, CC BY-SA 4.0, via Wikimedia Commons ↗Magnesium L-threonate has unique ability to increase brain magnesium concentration via superior blood-brain-barrier penetrance. Uses both magnesium threonate and glycine for sleep optimization.
peterattiamd.com ↗Attribution only; no endorsement implied.
Recommends organic magnesium salts (glycinate, citrate, taurate) over inorganic oxide/sulfate due to higher bioavailability. Cautions that magnesium threonate contains very low elemental magnesium and should not count toward RDA. Emphasizes divided dosing to maximize absorption. Glycinate taken before bed for nervous system calming.
www.foundmyfitness.com ↗Attribution only; no endorsement implied.
Which Magnesium should you buy?
The short version: plain magnesium is the most-studied and least-expensive form, and any product that is third-party certified is a safe bet. Certification (NSF Certified for Sport or USP Verified) screens for banned substances and confirms the label matches what is in the bottle. Here are recognizable brands that carry it. We do not certify products and take no payment to list them.
13 Magnesium products are third-party certified in total. See the full list →
Published lab tests on Magnesium
These studies test the ingredient category, not a single branded product. All attributed to their original source. We do not run the tests.
Two of 15 tested magnesium supplements received 'Not Approved' status because they appeared to contain a cheaper oxide form instead of the claimed glycinate or aspartate, based on the ratio of listed ingredient to actual elemental magnesium measured. Serving sizes ranged from 76 mg to 500 mg; cost per 200 mg varied from $0.02 to over $1.00.
Comparative heavy-metal chart of magnesium supplements found no uncontaminated magnesium glycinate product as of September 2025. CALM Magnesium Citrate Gummy was the only product with non-detect results for all four metals. Products testing positive for lead include Pure Encapsulations Magnesium Glycinate, Nordic Naturals Magnesium Complex, and Doctor's Best High Absorption Magnesium. Organics Ocean Pure Magnesium Glycinate was described as the most heavily lead-contaminated tested. Tablet forms showed higher contamination on average than capsule forms.
Sources
- Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2025) review
- Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis (2021) review
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial (2024) rct
- Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial (2025) rct
- A Randomized Double-blind Placebo-controlled Trial on the Effect of Magnesium Oxide in Patients With Chronic Constipation (2019) rct
- Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials (2025) review